Gentian Diagnostics ASA(DE:6FK)
€3.72+0.07 (+3.05%)
DE:6FK
Gentian Diagnostics ASA financials statements
€3.72
At close:+0.07 (+3.05%)
Gentian Diagnostics ASA (6FK) Ratios
0 Followers
Gentian Diagnostics ASA Ratios
DE:6FK's free cash flow for Q3 2026 was kr12.68M. For the 2026 fiscal year, DE:6FK's free cash flow was decreased by kr-2.17M and operating cash flow was kr14.86M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.40 | 5.38 | 5.60 | 6.33 | 7.42 |
| Quick Ratio | 3.81 | 3.85 | 4.13 | 4.58 | 6.10 |
| Cash Ratio | 3.10 | 2.81 | 3.46 | 3.71 | 5.10 |
| Solvency Ratio | 0.42 | 1.52 | -0.12 | -0.52 | -0.54 |
| Operating Cash Flow Ratio | 1.25 | 0.45 | 0.61 | -0.63 | -1.20 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 2.97 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 130.76M | kr 126.34M | kr 107.33M | kr 105.71M | kr 130.27M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.04 | 0.07 | 0.08 | 0.09 |
| Debt-to-Equity Ratio | 0.11 | 0.05 | 0.09 | 0.10 | 0.11 |
| Debt-to-Capital Ratio | 0.10 | 0.05 | 0.08 | 0.09 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.26 | 1.18 | 1.23 | 1.22 | 1.21 |
| Debt Service Coverage Ratio | 3.34 | 8.06 | -3.86 | -12.38 | -12.64 |
| Interest Coverage Ratio | 3.97 | 6.25 | -14.65 | -17.63 | -15.71 |
| Debt to Market Cap | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.83 | 0.81 | 0.90 | 1.08 | 1.30 |
| Net Debt to EBITDA | -2.78 | -2.37 | 24.19 | 4.16 | 5.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 55.64% | 54.46% | 47.94% | 48.21% | 48.06% |
| EBIT Margin | 11.73% | 14.85% | -7.03% | -22.00% | -28.17% |
| EBITDA Margin | 16.89% | 20.74% | -2.26% | -15.68% | -22.12% |
| Operating Profit Margin | 11.73% | 10.34% | -9.37% | -22.86% | -27.49% |
| Pretax Profit Margin | 14.54% | 13.19% | -7.61% | -23.24% | -29.83% |
| Net Profit Margin | 7.51% | 29.78% | -7.82% | -23.61% | -29.83% |
| Continuous Operations Profit Margin | 7.51% | 29.78% | -7.82% | -23.24% | -29.83% |
| Net Income Per EBT | 51.65% | 225.74% | 102.72% | 101.62% | 100.00% |
| EBT Per EBIT | 123.98% | 127.61% | 81.23% | 101.65% | 108.51% |
| Return on Assets (ROA) | 5.13% | 19.72% | -5.88% | -12.78% | -11.71% |
| Return on Equity (ROE) | 6.47% | 23.34% | -7.26% | -15.57% | -14.19% |
| Return on Capital Employed (ROCE) | 9.23% | 7.88% | -8.20% | -14.01% | -12.07% |
| Return on Invested Capital (ROIC) | 4.69% | 7.54% | -7.99% | -13.71% | -11.82% |
| Return on Tangible Assets | 5.95% | 22.51% | -6.66% | -14.91% | -13.27% |
| Earnings Yield | 1.52% | 7.49% | -1.66% | -3.80% | -2.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.27 | 4.86 | 8.02 | 5.30 | 3.68 |
| Payables Turnover | 2.29 | 10.58 | 19.13 | 11.85 | 8.68 |
| Inventory Turnover | 1.45 | 1.51 | 1.91 | 1.37 | 1.45 |
| Fixed Asset Turnover | 6.91 | 10.84 | 7.55 | 4.70 | 4.27 |
| Asset Turnover | 0.68 | 0.66 | 0.75 | 0.54 | 0.39 |
| Working Capital Turnover Ratio | 1.25 | 1.23 | 1.17 | 0.78 | 0.53 |
| Cash Conversion Cycle | 143.43 | 282.70 | 217.48 | 305.38 | 308.83 |
| Days of Sales Outstanding | 50.19 | 75.06 | 45.50 | 68.91 | 99.15 |
| Days of Inventory Outstanding | 252.39 | 242.14 | 191.06 | 267.29 | 251.74 |
| Days of Payables Outstanding | 159.15 | 34.51 | 19.08 | 30.81 | 42.06 |
| Operating Cycle | 302.58 | 317.20 | 236.56 | 336.19 | 350.89 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.76 | 0.87 | 1.00 | -0.90 | -1.75 |
| Free Cash Flow Per Share | 2.06 | 0.16 | 0.71 | -1.86 | -2.59 |
| Dividend Paid and CapEx Coverage Ratio | 2.52 | 1.23 | 3.45 | -0.95 | -2.11 |
| Capital Expenditure Coverage Ratio | 3.96 | 1.23 | 3.45 | -0.95 | -2.11 |
| Operating Cash Flow Coverage Ratio | 1.85 | 1.34 | 1.18 | -0.91 | -1.46 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.09 | 0.11 | -0.14 | -0.33 |
| Free Cash Flow Yield | 3.66% | 0.41% | 1.71% | -4.53% | -3.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 65.58 | 13.33 | -60.11 | -26.34 | -44.76 |
| Price-to-Sales (P/S) Ratio | 4.93 | 3.98 | 4.70 | 6.22 | 13.35 |
| Price-to-Book (P/B) Ratio | 4.24 | 3.12 | 4.36 | 4.10 | 6.35 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 27.33 | 241.15 | 58.34 | -22.09 | -27.84 |
| Price-to-Operating Cash Flow Ratio | 20.42 | 44.93 | 41.40 | -45.32 | -41.03 |
| Price-to-Earnings Growth (PEG) Ratio | -0.93 | -0.03 | 1.08 | 8.48 | -0.99 |
| Enterprise Value Multiple | 26.39 | 16.80 | -183.40 | -35.51 | -55.13 |
| Enterprise Value | 786.88M | 529.86M | 565.43M | 566.03M | 1.01B |
| EV to EBITDA | 26.39 | 16.80 | -183.40 | -35.51 | -55.13 |
| EV to Sales | 4.46 | 3.48 | 4.15 | 5.57 | 12.19 |
| EV to Free Cash Flow | 24.72 | 211.35 | 51.54 | -19.78 | -25.42 |
| EV to Operating Cash Flow | 18.48 | 39.37 | 36.58 | -40.57 | -37.46 |
| Tangible Book Value Per Share | 10.97 | 10.74 | 8.14 | 8.26 | 9.72 |
| Shareholders’ Equity Per Share | 13.29 | 12.58 | 9.51 | 10.00 | 11.34 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.48 | -1.26 | -0.03 | -0.02 | 0.00 |
| Revenue Per Share | 11.44 | 9.86 | 8.83 | 6.59 | 5.39 |
| Net Income Per Share | 0.86 | 2.94 | -0.69 | -1.56 | -1.61 |
| Tax Burden | 0.52 | 2.26 | 1.03 | 1.02 | 1.00 |
| Interest Burden | 1.24 | 0.89 | 1.08 | 1.06 | 1.06 |
| Research & Development to Revenue | 0.13 | 0.14 | 0.26 | 0.24 | 0.32 |
| SG&A to Revenue | 0.31 | 0.33 | 0.18 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.03 | 0.06 |
| Income Quality | 1.66 | 0.67 | -1.45 | 0.59 | 1.09 |
Currency in NOK
